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DANCE ROUND
We dance round in a ring and suppose,
But the Secret sits in the middle and knows.
Robert Frost
Introduction
The prevalence of overweight and obesity has risen in recent 
years, causing a global public health problem due to an in-
creased risk for the development of cardiometabolic diseases 
(atherosclerosis, hypertension, type 2 diabetes mellitus, meta-
bolic syndrome) and cancers (1). The white adipose tissue 
(WAT) is a major player in the link between overweight and 
health complications. One factor is the fat storage capacity of 
the WAT because lipid overload leads to ectopic lipid accumula-
tion in other peripheral tissues like skeletal muscle (2) and liver 
(3). This often leads to insulin resistance (4). Another role of the 
WAT in the link between overweight and health complications 
lies in the secretion by the adipocytes of over 600 peptide hor-
mones, referred to as adipokines (5), which regulate whole body 
metabolism (5, 6). When people become obese, the profile of se-
creted peptide hormones changes as for instance is obvious from 
a decrease in the plasma level of adiponectin, a multifunctional 
adipokine that increases glucose uptake by skeletal muscle. 
Obesity and weight loss
Weight loss is an indicated remedy for overweight/obesity that 
can reduce these risks. Already at 5% weight loss a decreased 
adipocyte size and an improved circulating adipokine profile 
was observed with obese woman after a 3-week low calorie 
diet (7). In addition we showed that the adipokine profile of 
in vitro cultured human Simpson-Golabi-Behmel syndrome 
(SGBS) adipocytes improved considerably after 96 hrs of glucose 
starvation (8). Despite these positive results, up to 80% of the 
people who lose weight on a low energy diet, regain weight and 
often return to their original weight or even beyond within one 
or two years (9). Previously we proposed the idea that adipocytes 
can reduce fat contents only to a certain degree because the 
remodeling of the extracellular matrix (ECM) cannot keep up 
with the rate of fat loss. As a consequence stress will build up 
between the ECM and the cell wall due to traction forces that will 
slow down a further release of fat (10). This idea resulted in new 
a study in which obese subjects were subjected to an 8-week diet 
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programme with a 10-month follow-up. Compared to weight 
maintainers, weight regainers showed increased expression of 
β-actin, calnexin, heat shock proteins (HSP) 27, HSP60 and 
HSP70 in their subcutaneous adipose tissue. This shows that 
cellular stress accumulated during weight loss appears a driving 
factor for weight regain. In a parallel experiment with human 
SGBS adipocytes increased levels of β-actin and HSP60 were 
observed after 96 hrs glucose starvation (8), indicating the 
suitability of this in vitro model to study starvation and weight 
regain in a more mechanistic manner. 
SGBS cells as model for mechanistic analysis of fat loss 
and regain
The SGBS cells proved to be a versatile model to study adipocyte 
differentiation and starvation in more detail (8, 11) (Fig. 1). As 
an extension to this, we will use starved SGBS adipocytes and 
study the refeeding process in relation to stress-induced weight-
regain. In the refeeding process, we will challenge the starved 
SGBS adipocytes with different glucose concentrations ranging 
from 0.55 mM to 17.5 mM or with different concentrations of 
fatty acids ranging from 0.5 mM to 5.0 mM (Fig. 2). Our ob-
jective is to find out the conditions that can prevent cell stress 
and prolong the reduced weight state in adipocytes. For this we 
will use Western blotting to monitor the expression of selected 
stress proteins. In addition we will use quantitative liquid chro-
matography tandem mass spectrometry (LC-MSMS) to discover 
changes in protein patterns that give further insight in the mo-
lecular mechanisms involved in starvation and refeeding. 
Conclusion
By using the SGBS model and our proteomics technology we 
can find out how a cycle of fat loss and regain alters the human 
adipocyte metabolism. This may open the way to find condi-
tions that can diminish cellular stress during fat loss and regain 
in man.
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Figure 1. Representative picutres of SGBS cells. SGBS preadipocytes (A), SGBS adipocytes (B), starved SGBS adipopcytes (C). Oil 
Red O (ORO) stained SGBS adipocytes (D) and ORO-stained starved SGBS adipocytes (E). T0: Differentiation stage, T1: Starvation 
procedure by low glucose concentrations (0.55 mM).
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Figure 2. Experimental set-up to study the starvation and refeeding processes in SGBS adipocytes. T0: Differentiation proce-
dure, T1: Starvation procedure with low (0.55 mM) glucose. T2: Refeeding procedure with 0.55 mM-17.5 mM glucose or 0.5 
mM-5.0 mM fatty acids.
